These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9218879)

  • 21. Serotonin receptor ligands: treatments of acute migraine and cluster headache.
    Goadsby PJ
    Handb Exp Pharmacol; 2007; (177):129-43. PubMed ID: 17087122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attacking migraine headache from beginning to end.
    Moskowitz MA; Cutrer FM
    Neurology; 1997 Nov; 49(5):1193-5. PubMed ID: 9371890
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeting the 5-HT
    Huang PC; Yang FC; Chang CM; Yang CP
    Prog Brain Res; 2020; 255():99-121. PubMed ID: 33008517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL; Goadsby PJ
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of action of the 5-HT1B/1D receptor agonists.
    Tepper SJ; Rapoport AM; Sheftell FD
    Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extending therapeutic options? Prospects for the future.
    Edmeads JG
    Eur Neurol; 1996; 36 Suppl 2():32-3. PubMed ID: 8791031
    [No Abstract]   [Full Text] [Related]  

  • 27. [Zolmitriptan].
    Monseu G; Sternon J
    Rev Med Brux; 1998 Dec; 19(6):495-9. PubMed ID: 9916496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A triptan too far?
    Goadsby PJ
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):143-7. PubMed ID: 9489518
    [No Abstract]   [Full Text] [Related]  

  • 29. 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine.
    Meng CQ; Rakhit S; Lee DK; Kamboj R; McCallum KL; Mazzocco L; Dyne K; Slassi A
    Bioorg Med Chem Lett; 2000 May; 10(9):903-5. PubMed ID: 10853656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5HT1B/1D agonists.
    Fox AW
    J Clin Pharmacol; 2002 Nov; 42(11):1281-2; author reply 1282-3. PubMed ID: 12412829
    [No Abstract]   [Full Text] [Related]  

  • 31. Is selective 5-HT
    Rubio-Beltrán E; Labastida-Ramírez A; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2018 Jun; 186():88-97. PubMed ID: 29352859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing the options for effective migraine management.
    Goadsby PJ; Olesen J
    Neurology; 1997 Mar; 48(3 Suppl 3):S1-3. PubMed ID: 9071262
    [No Abstract]   [Full Text] [Related]  

  • 33. Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials.
    Diener HC; Dowson AJ; Ferrari M; Nappi G; Tfelt-Hansen P
    Cephalalgia; 1999 Oct; 19(8):699-700. PubMed ID: 10570722
    [No Abstract]   [Full Text] [Related]  

  • 34. Emerging preclinical and clinical profile of 311C90: a poster review and discussion.
    Ferrari MD
    Eur Neurol; 1996; 36 Suppl 2():19-23. PubMed ID: 8791028
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of the trigemino-vascular system with 5-HT1D agonist drugs: selectively targeting additional sites of action.
    Martin GR
    Eur Neurol; 1996; 36 Suppl 2():13-8. PubMed ID: 8791027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Meta-analysis of triptan treatment in migraine].
    Nakashima K; Takeshima T; Kowa H
    No To Shinkei; 2004 Sep; 56(9):747-52. PubMed ID: 15552863
    [No Abstract]   [Full Text] [Related]  

  • 37. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
    Limmroth V; Kazarawa Z; Fritsche G; Diener HC
    Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449
    [No Abstract]   [Full Text] [Related]  

  • 38. Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices.
    Stepień A; Chalimoniuk M; Strosznajder J
    Cephalalgia; 1999 Dec; 19(10):859-65. PubMed ID: 10668104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs.
    Ramírez Rosas MB; Labruijere S; Villalón CM; Maassen Vandenbrink A
    Expert Opin Pharmacother; 2013 Aug; 14(12):1599-610. PubMed ID: 23815106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triptans to the rescue: effective therapy for migraine headaches in the workplace.
    Bartleson JD
    Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.